Search





Search





Markets
/
Stocks
/
nasdaq-cai
/

Caris Life Sciences Inc

CAI

Add to Watchlist

14.445USD

-0.805-5.28%

Market hours （ET）Quotes delayed by 15 min

4.08BMarket Cap

LossP/E TTM



Caris Life Sciences Inc

14.445

-0.805-5.28%

Overview Financials Discussions Analysis Company

Overview

Financials

Discussions

Analysis

Company

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Caris Life Sciences Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

204.91%32.88M

--44.78M

--62.42M

--7.29M

---31.34M

Net income from continuing operations

99.50%-510.00K

--81.96M

--24.32M

---71.79M

---102.58M

Operating gains losses

-28.11%5.07M

--4.29M

--4.87M

--6.41M

--7.04M

Other non-cash items

7.99%4.16M

--4.26M

--3.41M

--27.94M

--3.85M

Change in working capital

-37.78%8.29M

---59.10M

--14.09M

---1.44M

--13.32M

-Change in receivables

173.26%21.62M

---91.02M

--24.19M

--29.13M

--7.91M

-Change in inventory

-746.68%-13.33M

---9.61M

---8.52M

---4.68M

--2.06M

-Change in prepaid expenses

-162.91%-1.55M

---345.00K

---2.54M

---4.74M

--2.47M

-Change in other current assets

325.00%153.00K

--374.00K

---660.00K

--298.00K

--36.00K

Cash from non-recurring investing activities

Cash from operating activities

204.91%32.88M

--44.78M

--62.42M

--7.29M

---31.34M

Investing cash flow

Net cash from continuing investing activities

284.60%10.34M

--5.09M

--7.09M

--1.39M

--2.69M

Capital expenditures

284.60%10.34M

--5.09M

--7.09M

--1.39M

--2.69M

Net cash flow from disposal of fixed assets

284.60%10.34M

--5.09M

--7.09M

--1.39M

--2.69M

Net cash flow from investment products

----

--0.00

Net cash flow from other investing activities

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

-284.60%-10.34M

---5.09M

---7.09M

---1.39M

---2.69M

Financing cash flow

Cash flow from continuous financing activities

-35.88%824.00K

--3.40M

---21.10M

--681.40M

--1.28M

Net cash flow from debt Issuance/repayment

-81.82%-40.00K

---39.00K

---23.00K

--23.84M

---22.00K

Net cash flow from common stock issuance/repurchase

100.00%0.00

---91.00K

--0.00

--528.46M

---22.00K

Net cash flow from preferred stock issuance/repurchase

----

--0.00

--121.24M

----

Proceeds from stock option exercised by employees

-35.84%920.00K

--3.86M

--1.15M

--1.19M

--1.43M

Proceeds from issuance of warrants

----

--0.00

--10.27M

----

Net cash flow from other financing activities

46.67%-56.00K

---333.00K

---22.23M

---3.60M

---105.00K

Net cash from non-recurrent financing activities

Net cash from financing activities

-35.88%824.00K

--3.40M

---21.10M

--681.40M

--1.28M

Net cash flow

Beginning cash balance

1076.05%800.04M

--756.98M

--722.69M

--35.29M

--68.03M

Current period cash flow changes

171.32%23.35M

--43.06M

--34.30M

--687.40M

---32.74M

Effect of exchange rate changes

-350.00%-10.00K

---29.00K

--62.00K

--93.00K

--4.00K

Ending cash balance

2233.21%823.39M

--800.04M

--756.98M

--722.69M

--35.29M

Free cash flow

166.22%22.53M

--39.69M

--55.33M

--5.90M

---34.03M

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

